Related Experiment Video
Updated: Jun 1, 2026

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
Epigenetic changes in cancer
1Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL) 08908 L'Hospitalet de Llobregat, Barcelona, Catalonia Spain.
Abstract:
Interest in epigenetics is now booming in all the biomedical fields. Initially, interest was sparked within the field of cancer research with the finding of global DNA hypomethylation events in the 1980s, followed by the CpG island hypermethylation of tumor suppressor genes in the 1990s and the approval of DNA demethylating drugs and histone deactylase inhibitors in the 2000s. For transformed cells, the arena is also expanding to include the wide spectrum of histone modification changes and the interaction with noncoding RNAs. What lies ahead is even more exciting, with the imminent completion of many human cancer epigenomes that will form the basis of better biomarkers and epigenetic drugs.
Insights
Epigenetics research is rapidly advancing, particularly in cancer. Future human cancer epigenome data will drive development of novel biomarkers and epigenetic therapies.
Area of Science:
- Biomedical research
- Cancer epigenetics
- Molecular biology
Background:
- Epigenetics has gained significant traction in biomedical fields, originating in cancer research.
- Key milestones include DNA hypomethylation (1980s), CpG island hypermethylation (1990s), and drug approvals (2000s).
- Current research encompasses histone modifications and noncoding RNA interactions in transformed cells.
Purpose of the Study:
- To highlight the expanding scope of epigenetics in biomedical research.
- To emphasize the historical progression of epigenetic discoveries in cancer.
- To forecast future directions in cancer epigenome research.
Main Methods:
- Review of historical epigenetic findings in cancer.
- Discussion of current research trends in epigenetics.
- Anticipation of future research based on epigenome completion.
Main Results:
- Epigenetics has evolved from DNA methylation to include histone modifications and noncoding RNAs.
- Significant progress has been made in understanding epigenetic alterations in cancer.
- Completion of human cancer epigenomes is imminent.
Conclusions:
- The field of epigenetics is rapidly expanding across biomedical disciplines.
- Upcoming human cancer epigenome data holds promise for improved diagnostics and therapeutics.
- Further research into histone modifications and noncoding RNAs is crucial for advancing epigenetic therapies.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Prevention
Some...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

